HIV type 1 genetic diversity and genotypic drug susceptibility in the Republic of Moldova

AIDS Research and Human Retroviruses

Volumn 17, Issue 13, 2001, Pages 1297-1304

  Pandrea, Ivona ^a,b   Apetrei, Cristian ^a,b   Descamps, Diane ^c   Collin, Gilles ^c   Damond, Florence ^c   Simon, Franois ^c   Brun Vzinet, Franois ^c   Robertson, David L ^d   Dimitrienco, Valeria ^e   Gheorghita, Stefan ^e   Pecec, Mihai ^f  

^a GR T Popa University of Iasi   (Romania)

^b CENTRE INTERNATIONAL DE RECHERCHES MÉDICALES DE FRANCEVILLE   (Gabon)

^c BICHAT HOSPITAL   (France)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e National AIDS Reference Center   (Moldova)

^f National Institute for Transfusional Haematology   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR;

ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; CULTURAL FACTOR; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEMALE; GENETIC VARIABILITY; GENOTYPE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MOLDOVA; NONHUMAN; PRIORITY JOURNAL; ROMANIA; SEQUENCE ANALYSIS; SERODIAGNOSIS; USSR; VIRUS ISOLATION; VIRUS MUTANT; VIRUS RECOMBINANT; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING;

ADOLESCENT; ADULT; AMINO ACID SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; FOUNDER EFFECT; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MALE; MOLDOVA; MOLECULAR SEQUENCE DATA; PHYLOGENY; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS);

EID: 0034803461     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922201750461375     Document Type: Article

References (26)

1. Molecular epidemiology of HIV-1 in the former Soviet Union: Analysis of env V3 sequences and their correlation with epidemiologic data
2. Simultaneous introduction of distinct HIV-1 subtypes into risk groups in Russia, Byelorussia and Lithuania
3. The HIV/AIDS epidemic in eastern Europe: Recent patterns and trends and their implications for policy-making
4. Molecular and biological characterization of Russian HIV-1 strains
5. HIV-1 genetic sub-type A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad
6. A sudden epidemic of HIV type 1 among injecting drug users in the former Soviet Union: Identification of subtype A, subtype B, and novel gagA/envB recombinants
7. Molecular epidemiology of an HIV-1 subtype A subcluster among injection drug users in the Southern Ukraine
8. Extreme founder effect in an HIV type 1 subtype A epidemic among drug users in Svetlogorsk, Belarus
9. An HIV type 1 subtype A outbreak among injecting drug users in Latvia
10. HIV-1 diversity in Romania
11. Synthetic peptide ELISAs for detection of and discrimination between group M and group O HIV type 1 infection
12. HIV type 1 diversity and the reliability of the heteroduplex mobility assay
13. Sensitive procedure for the amplification of HIV-1 RNA using combined reverse-transcription and amplification reaction
14. Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility
15. Stochastic processes strongly influence HIV-1 evolution during suboptimal protease-inhibitor therapy
16. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice
17. Antiretroviral drug resistance testing in adult HIV-1 infection
18. An AB recombinant and its parental HIV type 1 strains in the area of the former Soviet Union: Low requirements for sequence identity in recombination
19. HIV-1 drug resistance in newly infected individuals
20. A recent outbreak of human immunodeficiency virus type 1 infection in southern China was initiated by two highly homogenous, geographically separated strains, circulating recombinant form AE and a novel BC recombinant
21. Genetic diversity of HIV-1: The moving target
22. Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay